[1] ZHU QingZHU YaoZHAO YifanCHEN Longju,.Analysis of Traditional Chinese Medicine Core Pathogenesis of Osteosarcoma [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2024, (02): 22-26. [doi: 10.13424/j.cnki.jsctcm.2024.02.005]
Analysis of Traditional Chinese Medicine Core Pathogenesis of Osteosarcoma
- Article number:
- 2096-1340(2024)02-0022-05
- Keywords:
- Key words： Osteosarcoma; Osteoma; Pathogenesis; Cancer toxin; Traditional Chinese medicine
- ZTFLH:
- R738.1
- Code:
- A
- Abstract:
- Abstract： Osteosarcoma,as a malignant bone tumor,has high metastasis,high treatment difficulty,and relatively limited means.Traditional Chinese medicine has certain advantages in anti-tumor treatment.Analyzing the pathogenesis of different patients is the key and characteristic of traditional Chinese medicine treatment.This article summarizes and analyzes the pathogenesis of ancient and modern literature,considering that it is mainly characterized by kidney deficiency,cold evil,blood stasis,and cancer toxin,mixed with deficiency and excess,and explores the transmission and injection of cancer toxin in osteosarcoma to provide ideas for clinical treatment.
References:
［1］Moukenge?B,Lallier?M,Marchandet?L,et?al.Origin?and?therapies?of?osteosarcoma［J］.Cancers?(Basel)，2022，14(14):3503.
［2］丁聚贤,谢兴文,许伟,等.中医药在骨肉瘤放化疗中的作用研究进展［J］.中医正骨,2018,30(5):43-46,49.
［3］尹萌辰,王洪伸,孙正望,等.骨肉瘤中医证候要素诊断量表的构建［J］.中华中医药杂志,2022,37(10):5938-5942.
［4］戴静静,侯黎莉.骨肉瘤患者中医体质特征与新辅助治疗并发症的相关性研究［J］.实用临床医药杂志,2021,25(22):38-41.
［5］李泉.40～60岁肢体骨肉瘤的临床治疗疗效与策略及骨肉瘤患者的舌诊分析［D］.济南：山东中医药大学,2021.
［6］鞠晓聪.规范化治疗后肢体骨肉瘤生存患者中医体质分析及其子女健康状况调查［D］.济南:山东中医药大学,2020.
［7］浦飞飞,陈凤霞,冯晶,等.湖北地区骨肉瘤患者中医证型与临床病理学的相关性分析［J］.中国中医骨伤科杂志,2019,27(9):42-45.
［8］司富春,丁帅伟.骨肉瘤中医证型与方药分析研究［J］.世界中西医结合杂志,2015,10(7):903-907.
［9］张彩霞,胡世云.寒湿,万病之源［J］.大众健康,2021,438(12):62.
［10］杨鸣,黄金昶.黄金昶教授中西医结合治疗骨肉瘤的临床思路和经验［C］第三届肿瘤阳光论坛暨中华中医药学会肿瘤创新共同体第二届会议论文集.中华中医药学会：2018:3.
［11］鲁佳敏,孙磊涛,傅钰涵，等.论“扶正解毒”与“解毒复正”辨治恶性肿瘤异同［J］.北京中医药大学学报,2023,46(3):421-426.
［12］程海波,王俊壹,李柳.癌毒病机分类及其在肿瘤临床治疗中的应用［J］.中医杂志,2019,60(2):119-122.
［13］赵智强,李嘉.略论周仲瑛教授的“癌毒”学说及其临床运用［J］.新中医,1998(10):7-9.
［14］陈四清.周仲瑛教授从癌毒辨治肿瘤经验［J］.新中医,2004(2):7-9.
［15］陈锐.张泽生癌证治疗心得［J］.中国社区医师,2012,28(8):21.
［16］高宇,郝淑兰,张福鹏,等.从“人体失和-癌毒传舍”探讨结直肠癌肝转移各阶段辨治思路［J］.中华中医药杂志,2022,37(10):5837-5840.
［17］钟佳,刘华,王理槐.基于“癌毒传舍”理论防治肺癌转移［J］.湖南中医药大学学报,2021,41(12):1950-1953.
［18］赵智强,吴勉华,赵延华.论恶性肿瘤中医辨治体系的建立［J］.中医杂志,2015,56(11):906-908.
［19］郭建辉.周仲瑛教授“癌毒学说”新论［J］.湖南中医药大学学报,2010,30(11):6-8.
［20］王珊珊.周仲瑛教授从痰瘀热毒辨治肺癌的临床经验及益肺解毒汤的抗肿瘤实验研究［D］.南京：南京中医药大学,2017.
［21］程海波.癌毒病机理论探讨［J］.中医杂志,2014,55(20):1711-1715.
［22］林小林,桑怡,刘丹,等.陈宝贵基于癌毒理论辨治肝癌之经验［J］.江苏中医药,2022,54(1):30-33.
［23］Zheng S,Chen L,Wang J,et al.A clinical prediction model for lung metastasis risk in osteosarcoma:A multicenter retrospective study［J］.Front Oncol,2023,13:1001219.
［24］许明贤,李瑞希,郭伟堂,等.基于高通量测序分析骨肉瘤发生和转移的分子特征［J］.中山大学学报(医学科学版),2022,43(6):985-994.
［25］Tang L,Liu B.Lung and bone metastases patterns in osteosarcoma:Chemotherapy improves overall survival［J］.Medicine (Baltimore),2023,102(4):e32692.
［26］朱岩,樊根涛,华晓烽,等.骨肉瘤脑转移七例报道［J］.中国骨与关节杂志,2021,10(2):117-121.
［27］邓立春,刘雄伟,曾洁,等.阿帕替尼治疗骨肉瘤脑转移1例［J］.肿瘤学杂志,2019,25(1):78-80.
［28］牟坤,张庆慧,申梦佳,等.乳腺的骨肉瘤转移［J］.临床与实验病理学杂志,2018,34(12):1364-1365.
［29］Vasiliev NV.Limfogennoe metastazirovanie sarkom kosti Lymph node metastasis of osteosarcomas［J］.Arkh Patol,2016,78(4):58-63.
［30］夏祥柱,于冬冬,李鑫.中医药治疗骨肉瘤的研究进展［J］.云南中医中药杂志,2021,42(11):83-87.
Memo
基金项目：国家自然科学基金项目（81260192）